Sequent Scientific, Viyash Life Sciences announce Rs 8,000 crore merger
Sequent Scientific and Viyash Life Sciences have announced a merger, creating a platform with leadership in animal pharmaceuticals and integrated capabilities across the global pharmaceutical market. The merger will expand Sequent’s capital base and is expected to enhance marketing presence, facilitate backward integration, and create procurement synergies.
The combined entities will have 16 manufacturing plants out of which 10 are US Food and Drug Administration approved plants.
| Subscribe To Our Free Newsletter |
